JP2005516004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005516004A5 JP2005516004A5 JP2003550776A JP2003550776A JP2005516004A5 JP 2005516004 A5 JP2005516004 A5 JP 2005516004A5 JP 2003550776 A JP2003550776 A JP 2003550776A JP 2003550776 A JP2003550776 A JP 2003550776A JP 2005516004 A5 JP2005516004 A5 JP 2005516004A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- receptor
- affinity
- composition according
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33673201P | 2001-12-07 | 2001-12-07 | |
| PCT/US2002/039310 WO2003049727A1 (en) | 2001-12-07 | 2002-12-09 | Treatment of neoplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005516004A JP2005516004A (ja) | 2005-06-02 |
| JP2005516004A5 true JP2005516004A5 (enExample) | 2006-02-02 |
Family
ID=23317407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003550776A Pending JP2005516004A (ja) | 2001-12-07 | 2002-12-09 | 新形成の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040259936A1 (enExample) |
| EP (1) | EP1461027A4 (enExample) |
| JP (1) | JP2005516004A (enExample) |
| AU (1) | AU2002357114B2 (enExample) |
| CA (1) | CA2468794A1 (enExample) |
| WO (1) | WO2003049727A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7632955B2 (en) * | 2001-12-13 | 2009-12-15 | National Health Research Institutes | Indole compounds |
| US7528165B2 (en) * | 2001-12-13 | 2009-05-05 | National Health Research Institutes | Indole compounds |
| WO2005023232A2 (en) * | 2003-09-04 | 2005-03-17 | Affibody Ab | Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| EP1736775A4 (en) * | 2004-04-12 | 2008-03-12 | Takeda Pharmaceutical | NEW LIGAND OF A G-PROTEIN-COUPLED RECEPTOR PROTEIN AND USE THEREOF |
| TWI360539B (en) | 2004-10-28 | 2012-03-21 | Shionogi & Co | 3-carbamoyl-2-pyridone derivatives |
| US7456289B2 (en) * | 2004-12-31 | 2008-11-25 | National Health Research Institutes | Anti-tumor compounds |
| MX2009005071A (es) * | 2006-11-13 | 2009-05-25 | Novartis Ag | Compuestos de pirazol y triazol sustituidos como inhibidores de ksp. |
| EP2470508A1 (en) | 2009-08-28 | 2012-07-04 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| CA2789151A1 (en) | 2010-02-08 | 2011-08-11 | Allergan, Inc. | Pyridazine derivatives useful as cannabinoid-2 agonists |
| US9597340B2 (en) | 2011-02-25 | 2017-03-21 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| MX392150B (es) | 2011-02-25 | 2025-03-21 | Arena Pharm Inc | Moduladores de receptores canabinoides. |
| JP5945554B2 (ja) | 2011-02-25 | 2016-07-05 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 縮合型アザ環の結晶形およびその調製プロセス（カンナビノイド受容体モジュレーター） |
| WO2016085941A1 (en) | 2014-11-25 | 2016-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of cannabinoid receptor modulators |
| CN114096241A (zh) * | 2019-05-16 | 2022-02-25 | 技术研究及发展基金有限公司 | 大麻素及其用途 |
| CN115282279B (zh) * | 2022-08-08 | 2024-03-12 | 暨南大学附属第一医院（广州华侨医院） | CNR2通过介导DCs成熟及功能作为脓毒症急性肺损伤治疗靶点的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1271266B (it) * | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
| FR2735774B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
| CA2340444A1 (en) * | 1998-05-04 | 1999-11-11 | The University Of Connecticut | Cannabinoids selective for the cb2 receptor |
| CA2387892A1 (en) * | 1999-10-18 | 2001-04-26 | University Of Connecticut | Pyrazole derivatives as cannabinoid receptor antagonists |
| FR2800372B1 (fr) * | 1999-11-03 | 2001-12-07 | Sanofi Synthelabo | Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant |
| JP2004502642A (ja) * | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
-
2002
- 2002-12-09 CA CA002468794A patent/CA2468794A1/en not_active Abandoned
- 2002-12-09 EP EP02804754A patent/EP1461027A4/en not_active Withdrawn
- 2002-12-09 AU AU2002357114A patent/AU2002357114B2/en not_active Ceased
- 2002-12-09 US US10/497,911 patent/US20040259936A1/en not_active Abandoned
- 2002-12-09 WO PCT/US2002/039310 patent/WO2003049727A1/en not_active Ceased
- 2002-12-09 JP JP2003550776A patent/JP2005516004A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013443D0 (no) | Triazolforbindelser med dopamin-D3-reseptoraktivitet | |
| DE69835539D1 (de) | Flexible phosphatisierte polyester-urethan-grundierungen und verbesserte beschichtungssysteme, die diese enthalten | |
| BRPI0113286B8 (pt) | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. | |
| PT1506185E (pt) | Compostos novos e sua utilizacao | |
| DE60002732D1 (de) | Digitales videoverarbeitungs- und speichersystem für video-, audio- und zusatzdaten | |
| DE60321920D1 (de) | Metallkomplexe der gruppe 4 des pse, die 4-aryl substituierte, tricyclische indenylderivate enthalten | |
| WO2004079564A3 (de) | Prozessor mit verschiedenartigen steuerwerken für gemeinsam genutzte ressourcen | |
| JP2005525089A5 (enExample) | ||
| CA2160101A1 (en) | Metallocene compound | |
| DE50311275D1 (de) | Blutstillungsmittel enthaltend polyvinylalkohol und seine bereitstellung für die medizin | |
| WO2004102854A3 (en) | Premium messaging exchange | |
| EP1074921A3 (en) | Business support system and recording medium | |
| JP2006527741A5 (enExample) | ||
| JP2004531567A5 (enExample) | ||
| JP2008517953A5 (enExample) | ||
| AU2001257913A1 (en) | Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications | |
| 瞿金平 et al. | Research on elastic behaviors of LDPE melt during capillary dynamic extrusion | |
| PT1105503E (pt) | Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada | |
| Snow | Apria to pay $1.7 million to settle kickback charges. | |
| Straub | Lives and livelihood on the line. | |
| JP2003140040A5 (enExample) | ||
| Zeitz | Impeach Johnson! | |
| Bell | Funny business in NY | |
| Shearer | Early History of Birth | |
| Lumsdon | Ready for cost cutting? One hospital mobilizes its resources. |